HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

K Mieras Selected Research

Cyclophosphamide (Cytoxan)

9/2013Clinical outcomes of remission induction therapy for severe antineutrophil cytoplasmic antibody-associated vasculitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


K Mieras Research Topics

Disease

1Vasculitis (Vasculitides)
09/2013
1Granulomatosis with Polyangiitis (Wegener's Granulomatosis)
09/2013
1Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
09/2013

Drug/Important Bio-Agent (IBA)

1Rituximab (Mabthera)FDA Link
09/2013
1Azathioprine (Imuran)FDA LinkGeneric
09/2013
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
09/2013
1Prednisone (Sone)FDA LinkGeneric
09/2013
1Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
09/2013

Therapy/Procedure

1Remission Induction
09/2013
1Therapeutics
09/2013